[go: up one dir, main page]

NO2010004I1 - 0.02 mg of ethinylostradiol (as betadexclathrate) and 3mg drospirenone - Google Patents

0.02 mg of ethinylostradiol (as betadexclathrate) and 3mg drospirenone

Info

Publication number
NO2010004I1
NO2010004I1 NO2010004C NO2010004C NO2010004I1 NO 2010004 I1 NO2010004 I1 NO 2010004I1 NO 2010004 C NO2010004 C NO 2010004C NO 2010004 C NO2010004 C NO 2010004C NO 2010004 I1 NO2010004 I1 NO 2010004I1
Authority
NO
Norway
Prior art keywords
ethinylostradiol
betadexclathrate
drospirenone
Prior art date
Application number
NO2010004C
Other languages
Norwegian (no)
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26153358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2010004(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/IB2000/001213 external-priority patent/WO2001015701A1/en
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of NO2010004I1 publication Critical patent/NO2010004I1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO2010004C 1999-08-31 2010-02-26 0.02 mg of ethinylostradiol (as betadexclathrate) and 3mg drospirenone NO2010004I1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24095399P 1999-08-31 1999-08-31
EP99202826 1999-08-31
PCT/IB2000/001213 WO2001015701A1 (en) 1999-08-31 2000-08-31 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

Publications (1)

Publication Number Publication Date
NO2010004I1 true NO2010004I1 (en) 2010-03-22

Family

ID=26153358

Family Applications (3)

Application Number Title Priority Date Filing Date
NO20083854A NO327588B3 (en) 1999-08-31 2008-09-08 Pharmaceutical composition and composition comprising ethinylostradiol and drospirenone for use as a contraceptive
NO20091809A NO20091809L (en) 1999-08-31 2009-05-07 Pharmaceutical material of entinylestradiol and drospirenone for use as a contraceptive
NO2010004C NO2010004I1 (en) 1999-08-31 2010-02-26 0.02 mg of ethinylostradiol (as betadexclathrate) and 3mg drospirenone

Family Applications Before (2)

Application Number Title Priority Date Filing Date
NO20083854A NO327588B3 (en) 1999-08-31 2008-09-08 Pharmaceutical composition and composition comprising ethinylostradiol and drospirenone for use as a contraceptive
NO20091809A NO20091809L (en) 1999-08-31 2009-05-07 Pharmaceutical material of entinylestradiol and drospirenone for use as a contraceptive

Country Status (11)

Country Link
CN (1) CN1223350C (en)
BG (2) BG65204B1 (en)
CA (1) CA2382426C (en)
EE (1) EE05317B1 (en)
HR (1) HRP20020258B1 (en)
IL (2) IL197396A (en)
MX (1) MXPA02002043A (en)
NO (3) NO327588B3 (en)
RU (4) RU2269342C2 (en)
SK (1) SK287634B6 (en)
UA (1) UA81387C2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1625849A1 (en) * 2004-08-09 2006-02-15 Liconsa, Liberacion Controlada de Sustancias Activas, S.A. Pharmaceutical composition comprising drospirenone and ethynylestradiol
CN101489563A (en) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 Pharmaceutical preparations for contraception and for preventing the risk of congenital malformations
EP3936133A1 (en) 2011-11-23 2022-01-12 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RU2618471C2 (en) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Oral pharmaceutical composition of diuretics and ace inhibitor in micronized form, drug and its application
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AR100562A1 (en) 2014-05-22 2016-10-12 Therapeuticsmd Inc PHARMACEUTICAL COMPOSITION OF ESTRADIOL AND PROGESTERONE FOR HORMONAL REPLACEMENT THERAPY
CN108606963B (en) * 2017-12-27 2021-05-18 上海长海医院 Compound contraceptive patch containing drospirenone and estrogen, preparation method and application
CN111529482A (en) * 2020-05-20 2020-08-14 祝培 Testosterone undecanoate sustained-release implant and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (en) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-methylene-spirolactones, processes for their preparation and pharmaceuticals containing them
DE4344462C2 (en) * 1993-12-22 1996-02-01 Schering Ag Composition for contraception
DE4411585A1 (en) * 1994-03-30 1995-10-05 Schering Ag Combined pharmaceutical preparation for hormonal contraception
JP2000515890A (en) * 1996-07-26 2000-11-28 アメリカン・ホーム・プロダクツ・コーポレイション Monophasic contraceptive method and kit comprising a mixture of progestin and estrogen

Also Published As

Publication number Publication date
BG65204B1 (en) 2007-07-31
EE05317B1 (en) 2010-08-16
SK287634B6 (en) 2011-04-05
MXPA02002043A (en) 2003-08-20
RU2269342C2 (en) 2006-02-10
CA2382426A1 (en) 2001-03-08
CN1407895A (en) 2003-04-02
UA81387C2 (en) 2008-01-10
NO20091809L (en) 2002-04-26
NO20083854L (en) 2002-04-26
BG109749A (en) 2008-06-30
CA2382426C (en) 2006-02-28
RU2005131868A (en) 2007-04-20
RU2269342C9 (en) 2007-10-27
CN1223350C (en) 2005-10-19
RU2449796C2 (en) 2006-02-10
RU2396082C2 (en) 2010-08-10
IL200482A0 (en) 2011-07-31
RU2010114825A (en) 2011-10-20
SK2572002A3 (en) 2002-11-06
RU2482853C2 (en) 2013-05-27
EE200900049A (en) 2009-10-15
HRP20020258A2 (en) 2005-02-28
HRP20020258B1 (en) 2007-05-31
IL197396A (en) 2010-04-29
RU2449796C9 (en) 2007-10-27
NO327588B3 (en) 2011-05-16
NO327588B1 (en) 2009-08-31
BG106533A (en) 2002-10-31

Similar Documents

Publication Publication Date Title
NO2010004I1 (en) 0.02 mg of ethinylostradiol (as betadexclathrate) and 3mg drospirenone
DK1202733T3 (en) 3 (5) -amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
NO20012058D0 (en) 2-ureido-thiazole derivatives, process for their preparation and use as antitumor agents
MXPA03001775A (en) Nucleoside derivatives.
NO991815L (en) Oxadiazoles, processes for their preparation and their use as drugs
MXPA02008801A (en) Indole derivatives, process for preparation of the same and use thereof.
TR200000520A3 (en) 4-Phenyl-pyridine derivatives.
NO20020687D0 (en) 3 (5) -ureidopyrazole derivatives, process for their preparation and their use as antitumor agents
DK1095025T3 (en) Benzimidazoles, their preparation and their use as drugs
NL1016224A1 (en) Photo-base-forming agent and photo-acid-forming agent containing photo-etching composition.
NO20011503D0 (en) Indeno-, naphtho- and benzocyclohepta-dihydrotiazole derivatives, their preparation and use as anorectic drugs
DK1083171T3 (en) Pyrazoline derivatives, their preparation and use as drugs
NO20005146L (en) Thienylazolylalkoxyethanamines, their preparation and their use as drugs
NO20006138D0 (en) Substituted indolinones, preparation and use thereof as drugs
MXPA03000753A (en) Benzimidazole derivatives, preparation and therapeutic use thereof.
ZA200109595B (en) 13-methyl-erythromycin derivatives.
NO20030800D0 (en) Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, process and preparation containing the same
AU2001264044A1 (en) 1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof
ZA996814B (en) Aluminosilicate compositions, preparation and use.
ZA200110150B (en) Streptogramin derivatives, preparation and compositions containing them.
NO20020156D0 (en) Titanium derived compounds, their preparation and their use
DK0912509T3 (en) Distamycin derivatives, processes for their preparation and their use as antitumor and antiviral agents
ZA200001490B (en) (Poly)thiaalkynoic compounds and their derivatives, compositions comprising them and their use.
ZA200205482B (en) Aminosulfonylbiphenyl derivatives.
ZA200206150B (en) Aminomethyl-phenyl-cyclohexanone derivatives.